CSE/ASTI (CSE/ASTI)

Canadian Securities Exchange: CSE/ASTI · CAD

CA$0.02

+0.00 (+50.0%)· Recorded snapshot

Market cap	414K
Revenue (ttm)	91.6K
Net income (ttm)	-1.5M
EPS (ttm)	-CA$0.05
Shares out	27.6M
Volume	1,370
Beta	1.48

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 91.6K
Net income (ttm): -1.5M
EPS (ttm): -CA$0.05
Market cap: 414K

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/En/a

P25 11P50 16.8P75 23.9

Trailing P/En/a

P25 9.9P50 23.3P75 38.5

ROEn/a

P25 -104.1P50 -30P75 6.7

ROIC-13.8

P25 -55.9P50 -12.1P75 5

Benchmarks · 1M

All CSE/ASTI indicators

Market & fundamental data

Available fields

149

Groups with data

Currency

CAD

Showing 149 of 149 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-27
Enterprise value	CAD 7.4M
Exchange	Canadian Securities Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1986
Industry	Medical Devices
Is primary listing	Yes
ISIN number	CA03842P1009
Last earnings date	2026-02-26
Last refreshed	2026-10-29
Market cap	CAD 413,988
Next earnings date	2026-11-27
Price	CAD 0.02
Price currency	CAD
Sector	Healthcare
SIC code	9995
Stock price date	2026-10-21
Symbol	cse/ASTI
Website	https://aquariussurgical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-366.23%
EV/Sales	81.21x
FCF / EV yield	-1.18%
FCF yield	-21.24%
P/S ratio	4.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-243.64%
Gross margin	53.42%
Operating margin	-243.64%
Pretax margin	-1,648.08%
ROA	-5.89%
ROA (5Y)	-36.51%
ROCE	316.66%
ROIC	-13.83%
Tax / revenue	6.7%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	7.85%
Gross profit growth (Q)	-1.38%
Gross profit growth 3Y	-6.65%
Gross profit growth 5Y	-25.28%
Net income growth years	1
Revenue growth	8.66%
Revenue growth (Q)	1.06%
Revenue growth (QoQ)	-44.95%
Revenue growth 3Y	-15.54%
Revenue growth 5Y	-29.89%
Revenue growth quarters	3
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	CAD 8,916
EBIT	CAD -223,224
EPS	CAD -0.05
FCF per share	CAD -0.00
Financing cash flow	CAD 121,320
Free cash flow	CAD -87,935
Gross profit	CAD 48,945
Income taxes	CAD 6,139
Net borrowing	CAD 121,320
Net cash flow	CAD 33,384
Net income	CAD -1.5M
Operating income	CAD -223,224
Revenue	CAD 91,622

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-27.85
Book value per share	CAD -0.24
Interest coverage	-0.57
Long-term assets	CAD 1.8M
Long-term liabilities	CAD 6.5M
Net cash (debt)	CAD -7M
Net cash / market cap	-1,697.38%
Piotroski F-Score	2
Shareholders' equity	CAD -6.6M
Tangible book value	CAD -6.6M
Tangible book value per share	CAD -0.24
Total assets	CAD 1.9M
Total cash	CAD 47,660
Total debt	CAD 7.1M
Total liabilities	CAD 8.5M
WACC	4.85%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.04
Current assets	CAD 104,132
Current liabilities	CAD 2M
Current ratio	0.05
Net working capital	CAD -1.3M
Quick ratio	0.04
Working capital	CAD -1.9M
Working capital turnover	-0.05

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 0.02
1D price change	50%
1M price change	50%
1M total return	50%
1W price change	50%
1W total return	50%
1Y price change	50%
1Y return CAGR	50.04%
1Y total return	50%
20-day SMA	CAD 0.01
200-day SMA	CAD 0.02
3M price change	50%
3M total return	50%
3Y price change	50%
3Y return CAGR	14.47%
3Y total return	50%
50-day SMA	CAD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	CAD 0.02
52-week high date	2026-08-21
52-week low	CAD 0.01
52-week low date	2026-09-15
5Y price change	-76.92%
5Y return CAGR	-25.42%
5Y total return	-76.92%
All-time high	CAD 1.00
All-time high date	2017-06-21
All-time low	CAD 0.01
All-time low date	2021-09-03
Average true range (ATR)	CAD 0.00
Average volume	22.6K
Beta (1Y)	-0.56
Beta (2Y)	-0.32
Beta (5Y)	1.48
Change from 52-week high	-25%
Change from 52-week low	50%
Change from all-time high	-98.5%
Change from all-time low	200%
Change from open	0%
Day's gap	50%
Dollar volume	CAD 20.55
High price	CAD 0.02
Low price	CAD 0.02
Monthly RSI	47.39
Open price	CAD 0.02
Previous close	CAD 0.01
Price vs 150-day SMA	-16.67%
Price vs 20-day SMA	11.11%
Price vs 200-day SMA	-23.08%
Price vs 50-day SMA	19.05%
Relative volume	0.06
RSI	52.16
Sharpe ratio	2.05
Sortino ratio	3.87
Volume	1.4K
Weekly RSI	45.75
YTD price change	50%
YTD total return	50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	0%
Shares outstanding	27.6M

Deeper analysis on CSE/ASTI

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CSE/ASTI report

Is a complete CSE/ASTI research report available?

No complete published report is available for cse/ASTI (CSE/ASTI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/ASTI (CSE/ASTI)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/ASTI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/ASTI indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on CSE/ASTI

Frequently asked questions